Common Stock, Shares, Outstanding of RECURSION PHARMACEUTICALS, INC. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
RECURSION PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • RECURSION PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 528,182,693, a 33% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 528,182,693 +131,380,299 +33% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 491,800,501 +205,676,222 +72% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 432,830,642 +151,862,366 +54% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 406,410,733 +168,902,051 +71% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 396,802,394 +162,532,010 +69% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 286,124,279 +69,810,597 +32% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 280,968,276 +74,230,944 +36% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 237,508,682 +45,277,828 +24% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 234,270,384 +43,247,520 +23% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 216,313,682 +42,240,776 +24% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 206,737,332 +33,921,923 +20% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 192,230,854 +21,152,766 +12% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 191,022,864 +20,750,402 +12% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 174,072,906 +5,437,947 +3.2% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 172,815,409 +4,389,502 +2.6% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 171,078,088 +147,041,363 +612% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 170,272,462 +147,957,777 +663% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 168,634,959 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 168,425,907 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 24,036,725 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 22,314,685 31 Dec 2020 10-K 23 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.